In Vitro Diagnostics News and Research

RSS
IVAX Diagnostics second quarter 2010 operating expenses decrease 11.9%

IVAX Diagnostics second quarter 2010 operating expenses decrease 11.9%

China Medical Technologies first-quarter fiscal 2010 revenues decrease 10.9% to RMB186.2 million

China Medical Technologies first-quarter fiscal 2010 revenues decrease 10.9% to RMB186.2 million

A*STAR's Singapore Immunology Network, Institut M-rieux and bioM-rieux partner in TB research

A*STAR's Singapore Immunology Network, Institut M-rieux and bioM-rieux partner in TB research

Transgenomic second-quarter net loss increases to $1.1 million

Transgenomic second-quarter net loss increases to $1.1 million

AdvanDx announces European launch of CE-IVD marked GNR Traffic Light PNA FISH test

AdvanDx announces European launch of CE-IVD marked GNR Traffic Light PNA FISH test

GenMark second-quarter revenues increase 162% to $651,000

GenMark second-quarter revenues increase 162% to $651,000

Epitomics launches EP Clone Rabbit Monoclonal Antibodies

Epitomics launches EP Clone Rabbit Monoclonal Antibodies

IL releases new HemosIL HIT-Ab(PF4-H) assay

IL releases new HemosIL HIT-Ab(PF4-H) assay

Merck-Chimie to commercialize CardioGenics' proprietary paramagnetic beads

Merck-Chimie to commercialize CardioGenics' proprietary paramagnetic beads

IRIS International closes AlliedPath acquisition

IRIS International closes AlliedPath acquisition

Affymetrix second-quarter total revenue decreases to $71.7 million

Affymetrix second-quarter total revenue decreases to $71.7 million

DermaGenoma announces availability of PsoriasisDX Genetic Test as CE Marked product for PsA

DermaGenoma announces availability of PsoriasisDX Genetic Test as CE Marked product for PsA

Corgenix, ELITech establish broad strategic alliance

Corgenix, ELITech establish broad strategic alliance

CardioGenics Holdings' subsidiary signs second product agreement with Merck Chimie

CardioGenics Holdings' subsidiary signs second product agreement with Merck Chimie

Accuri Cytometers announces completion of $6 million Series E preferred stock financing

Accuri Cytometers announces completion of $6 million Series E preferred stock financing

IncellDx's HPV OncoTect E6/E7 mRNA kit increases specificity compared to other HPV tests

IncellDx's HPV OncoTect E6/E7 mRNA kit increases specificity compared to other HPV tests

IRIS submits 510(k) application for clearance of iChemVELOCITY and iRICELL Urinalysis Workstation

IRIS submits 510(k) application for clearance of iChemVELOCITY and iRICELL Urinalysis Workstation

Signature Dx obtains worldwide license to Affymetrix microarray technology for development of CRC tests

Signature Dx obtains worldwide license to Affymetrix microarray technology for development of CRC tests

AMP comments on barriers to market for molecular diagnostic tests at FDA CDRH meeting

AMP comments on barriers to market for molecular diagnostic tests at FDA CDRH meeting

CardioGenics announces clinical test sites for QL Care portable blood analyzer

CardioGenics announces clinical test sites for QL Care portable blood analyzer